Details

---

Manufacturer:

- Novo Nordisk Pharma (Malaysia) Sdn. Bhd.

Registration Number:

- MAL22056044AZ

Content:

- Semaglutide 3 mg per tablet

• ingredients:

  • Salcaprozate sodium

  • Povidone K90

  • Microcrystalline cellulose

  • Magnesium stearate

 

Indications:

- Rybelsus is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise:

• As monotherapy when metformin is considered inappropriate due to intolerance or contraindications

• In combination with other medicinal products for the treatment of diabetes

 

Instructions:

• Take one tablet daily on an empty stomach, at least 30 minutes before the first food, beverage, or other oral medications of the day

• Swallow the tablet whole with no more than 4 ounces (approximately 120 mL) of plain water

• Do not split, crush, or chew the tablet

• After taking Rybelsus, wait at least 30 minutes before eating, drinking, or taking other oral medications